Rate My Professor Subhrangsu Mandal
Ratings & reviews
Always clear, concise, and insightful.
This comment is not public.
Taught by or worked with Subhrangsu?
Add your rating. It takes about 30 seconds.
About Subhrangsu
Subhrangsu Mandal is a Professor of Biochemistry and Associate Department Chair in the Department of Chemistry and Biochemistry at the University of Texas at Arlington. He received his Ph.D. in Chemistry from the Indian Institute of Science, India, M.Sc. in Chemistry from the University of Kalyani, India, and B.Sc. (Honors) in Chemistry from Vidyasagar University, India. After completing postdoctoral research at the University of Alberta as an Alberta Heritage Foundation for Medical Research Fellow and at the University of Medicine and Dentistry of New Jersey as a Howard Hughes Medical Institute postdoctoral fellow, he joined the University of Texas at Arlington in 2005 as Assistant Professor of Biochemistry. He was promoted to Associate Professor in 2011 and to Professor in 2019, and assumed the role of Associate Department Chair in 2023.
Mandal's research investigates the biochemistry of human gene regulation, epigenetics, and disease, focusing on chromatin modifications, noncoding RNAs, steroid hormone signaling, endocrine disruption, inflammation, and their roles in cardiovascular diseases, neurological disorders, and cancer. His laboratory employs cell culture, animal models, and patient samples to study hormone signaling networks disrupted by environmental endocrine disruptors and develops novel small-molecule therapeutics targeting macrophage activation, inflammation, metabolic diseases, and cancer immunotherapy. He has published over 75 peer-reviewed articles, multiple book chapters, reviews, and holds patents. Key publications include 'Long Noncoding RNA and Cancer: A New Paradigm' (Cancer Research, 2017), 'Antisense Transcript Long Noncoding RNA HOTAIR is Transcriptionally Induced by Estradiol' (Journal of Molecular Biology, 2013), 'Novel long-noncoding RNAs associated with inflammation and macrophage activation in Human' (Scientific Reports, 2023), and 'HDLR-SR-BI expression and cholesterol uptake is regulated via Indoleamine-2,3-dioxygenase 1 in macrophages under inflammation' (Langmuir, 2025). His scholarship has earned over 10,000 citations. Awards include the Distinguished Record of Research Award from the College of Science at UTA (2025), Outstanding Research Award (2013), Research Excellence Award (2008), Gold Medal from Chirantan Rasayan Sanstha (2017), and FEBS Journal Top-Cited Paper Award (2012). He serves as Section Editor for Heliyon Cancer Research, Associate Editor for Frontiers in Endocrinology, and Editorial Board Member for Scientific Reports.
Trending Research & Publication News
SPARC Cost of Knowledge Study: 95% Public Investment in Articles
Photo by Precondo CA on Unsplash
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Informa Taylor & Francis Split & Clarion Deal | AcademicJobs
Photo by Anne Nygård on Unsplash
arXiv Two-Submission Monthly Cap Explained | AcademicJobs
Photo by Kelly Sikkema on Unsplash
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
Society Journal Sales & Nonprofit Consolidations | AcademicJobs
Photo by Philip Strong on Unsplash